Menstrual factors, reproductive factors and lung cancer risk: A meta-analysis

Chinese Journal of Lung Cancer

Volumn 15, Issue 12, 2012, Pages 701-719

  Zhang, Yue ^a,b   Yin, Zhihua ^a,b   Shen, Li ^a,b   Wan, Yan ^a,b   Zhou, Baosen ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY   (China)

Author keywords

Age at menarche; Female sex hormones; Length of menstrual cycle; Lung neoplasms

Indexed keywords

SEX HORMONE;

ARTICLE; CANCER RISK; GENETIC HETEROGENEITY; LUNG CANCER; MENSTRUATION; META ANALYSIS; NONHUMAN; REPRODUCTION; RISK FACTOR;

EID: 84922687215     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2012.12.04     Document Type: Article

References (60)

1. Baldini EH, Strauss GM. Women and lung cancer: waiting to exhale. Chest, 1997, 112(4S): 229S-234S.
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin, 2010, 60(5): 277-300.
3. Chakraborty S, Ganti AK, Marr A, et al. Lung cancer in women: role of estrogens. Expert Rev Respir Med, 2010, 4(4): 509-518.
4. Mollerup S, Jorgensen K, Berge G, et al. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer, 2002, 37(2): 153-159.
5. Liao YD, Fu XN, Zhou S, et al. The expression of estrogen receptor in human adenocarcinoma and squamous cell carcinoma of lung. Central China Medical Journal, 2003, 27(6): 307-308.
6. Hammoud Z, Tan B, Badve S, et al. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer, 2008, 15(2): 475-483.
7. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 2000, 283(15): 2008-2012.
8. Higgins JP, SG Thompson. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002, 21(11): 1539-1558.
9. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560.
10. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315(7109): 629-634.
11. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 50(4): 1088-1101.
12. Fan RL, Zheng SH, Wu ZS, et al. Study on relationship between lung cancer in women and some factors in body. Tumor, 1997, 6(9): 11-12.
13. Zheng SH, Fan RL, Cao LH, et al. Study on the etiology of lung cancer among women in Beijing. Chin J Lung Cancer, 2000, 3(4): 299-300.
14. Dorjgochoo T, Shu XO, Li HL, et al. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer, 2009, 124(10): 2442-2449.
15. Liu XX, Qian MH, Zou H, et al. A case-control study of the risk factors for lung cancer in non-smoking women. Chin Primary Health Care, 2010, 24(9): 64-65.
16. Zhong LJ, Zheng W, Jin F, et al. Multivariate Logistic Regression analysis for lung cancer risk factors. Tumor, 1991, 11(6): 251-254.
17. Qin Y, Zhou BS, Xu ZY. A case-control study on risk factor of lung cancer in female nonsmokers. Chin J Lung Cancer, 2002, 5(2): 98-100.
18. Yin ZH, Li MC, He QC, et al. A case-control study on relationship between lung cancer in non-smok ing women and menstrual and reproductive factors. China Public Health, 2005, 21(12): 1456-1457.
19. Fang J, Gan DK, Zheng SH, et al. A case-control study of risk factors for lung cancer among Chinese women who have never smoked. Wei Sheng Yan Jiu, 2006, 35(4): 464-467.
20. Skuladottir H, Olsen JH. Can reproductive pattern explain better survival of women with lung cancer? Acta Oncol, 2006, 45(1): 47-53.
21. Wu AH, Yu MC, Thomas DC, et al. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res, 1988, 48(24 Pt 1): 7279-7284.
22. Zheng W, Gao YT, Sun L. A study on the association between lung cancer and menstrual and reproductive history. Tumor, 1988, 8(3): 150-153.
23. Wu-Williams AH, Dai XD, Blot W, et al. Lung cancer among women in north-east China. Br J Cancer, 1990, 62(6): 982-987.
24. Taioli E, Wynder EL. Wynder, Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst, 1994, 86(11): 869-870.
25. Wynder EL, Stellman SD. Stellman, comparative epidemiology of tobacco-related cancers. Cancer Res, 1977, 37(12): 4608-4622.
26. Zhou BS, Wang TJ, Zhang QD, et al. The risk factors of female lung adenocarcinoma. China Public Health, 2000, 16(6): 536-539.
27. Kubík AK, Zatloukal P, Tomásek L, et al. Lung cancer risk among Czech women: a case-control study. Prev Med, 2002, 34(4): 436-444.
28. Seow A, Poh WT, Teh M, et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer, 2002, 97(3): 365-371.
29. Kreuzer M, Gerken M, Heinrich J, et al. Hormonal factors and risk of lung cancer among women? Int J Epidemiol, 2003, 32(2): 263-271.
30. Xiang YB, Gao YT. A population-based case-control study of lung cancer between young and older nonsmoking women in urban Shanghai, P. R. China. Tumor, 2003, 23(6): 452-457.
31. Brenner AV, Wang ZY, Kleinerman RA, et al. Influence of menstrual and reproductive factors on the risk of lung cancer. Zhonghua Liu Xing Bing Xue Za Zhi, 2004, 25(7): 590-593.
32. Liu Y, Inoue M, Sobue T, et al. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer, 2005, 117(4): 662-666.
33. Elliott AM, Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception, 2006, 73(4): 331-335.
34. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer, 2007, 120(10): 2214-2220.
35. Matsuo K, Ito H, Yatabe Y, et al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci, 2007, 98(1): 96-101.
36. Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol, 2007, 25(36): 5785-5792.
37. Chen J. An epidemiologic study on the risk factors of lung cancer. Fujian Medical University, 2008.
38. Weiss JM, Lacey JV Jr, Shu XO, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol, 2008, 168(11): 1319-1325.
39. Chen W. A cohort study on risk factors of Iung cancer among nonsmoking women in urban Shanghai. Fudan University, 2009.
40. Koushik A, Parent ME, Siemiatycki J. Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer, 2009, 125(10): 2428-2433.
41. Seow A, Koh WP, Wang R, et al. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev, 2009, 18(3): 821-827.
42. Baik CS, Strauss GM, Speizer FE, et al. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev, 2010, 19(10): 2525-2533.
43. Lin Y, Chen X, Huang M, et al. A case-control study of risk factors for female lung cancer. J Fujian Med Univ, 2010, 44(4): 239-243.
44. Meinhold CL, Berrington de González A, Bowman ED, e t al. Reproductive and hormonal factors and the risk of nonsmall cell lung cancer. Int J Cancer, 2010, 128(6): 1404-1413.
45. Paulus JK, Asomaning K, Kraft P, et al. Parity and risk of lung cancer in women. Am J Epidemiol, 2010, 171(5): 557-563.
46. Brinton LA, Gierach GL, Andaya A, et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev, 2011, 20(5): 900-911.
47. Gao YT, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer, 1987, 40(5): 604-609.
48. Zatloukal P, Kubík A, Pauk N, et al. Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer, 2003, 41(3): 283-293.
49. Brenner AV, Wang Z, Kleinerman RA, et al. Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998. J Epidemiol, 2003, 13(1): 22-28.
50. Zhang G, Liu X, Farkas AM, et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol, 2009, 23(2): 146-156.
51. Lin S, Lin CJ, Hsieh DP, et al. ERalpha phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells. Lung Cancer, 2012, 75(3): 285-292.
52. Tsuchiya Y, Nakajima M, Yokoi T. Cy tochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett, 2005, 227(2): 115-124.
53. Raso MG, Behrens C, Her ynk MH, et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res, 2009, 15(17): 5359-5368.
54. Nose N, Sugio K, Oyama T, et al. Association between estrogen receptorbeta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. J Clin Oncol, 2009, 27(3): 411-417.
55. Stabile LP, Lyker JS, Gubish CT, et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res, 2005, 65(4): 1459-1470.
56. Zhao G. The mechanisms of estrogen receptor β promoting the progression of lung adenocarcinoma, in physiology. Nanjing University, 2011.
57. Henningson M, Johansson U, Borg A, et al. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women. Mol Hum Reprod, 2007, 13(4): 231-236.
58. Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res, 1998, 58(4): 585-587.
59. Haiman CA, Hankinson SE, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res, 1999, 59(5): 1015-1020.
60. Onland-Moret NC, van Gils CH, Roest M, et al. Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 2005, 14(4): 815-820.